Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Igor Roninson
President
roninson@senexbio.com

Message the company or request a 1:1 meeting here

Senex Biotechnology is a drug discovery and development company focused on cancer therapeutics. Senex’s lead program targets a protein that is required by cancer cells to adapt to adversarial conditions; such adaptation leads to cancer drug resistance and metastasis. Senex is developing highly selective small-molecule inhibitors of this protein for the treatment of presently incurable types of prostate cancer, breast cancer and leukemia. Our latest, highly potent and selective drug candidate is anticipated to enter clinical trials within a year.

Executive Summary